Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment

2016 ◽  
Vol 13 (12) ◽  
pp. 1337-1345 ◽  
Author(s):  
Jie Sun ◽  
Wenqing Xia ◽  
Rongrong Cai ◽  
Pin Wang ◽  
Rong Huang ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Serum Insulin ◽  
Enzyme Level ◽  
Diabetic Patients ◽  
Insulin Degrading Enzyme ◽  
Type 2 Diabetic Patients ◽  
Degrading Enzyme ◽  
Type 2 Diabetic

Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients

2017 ◽  
Vol 14 (6) ◽  
pp. 592-597 ◽  
Author(s):  
Jin-biao Zhang ◽  
Yan-nan Cong ◽  
Zhen-Guang Li ◽  
Hai-Rong Sun ◽  
Jiang-Shan Zhang ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Plasma Phospholipids ◽  
Type 2 Diabetic

scholarly journals Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients

Oncotarget ◽  
2017 ◽  
Vol 8 (9) ◽  
pp. 15126-15135 ◽  
Author(s):  
Rong Huang ◽  
Jing Han ◽  
Sai Tian ◽  
Rongrong Cai ◽  
Jie Sun ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

scholarly journals Mild cognitive impairment among type 2 diabetic patients attending Zagazig University outpatient clinics

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
N H Elshamy ◽  
I I Salama ◽  
M S Gabal ◽  
A M Hassan ◽  
G A Abdellatif
Keyword(s):  
Type 2 Diabetes ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Cognitive Disorders ◽  
Outpatient Clinics ◽  
Control Group ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Abstract Objective The incidence of mild cognitive impairment increases with age, so this study is conducted to assess the relation between mild cognitive impairment and type 2 diabetes. Methods 100 type 2 diabetic patients attending Zagazig University outpatient clinics with age range from 40-60 years old was included in the study. These patients were matched with 100 non-diabetic controls regarding age, sex and educational class. Patients with important risk factors for cognitive disorders (cerebro-vascular stroke, organ failure, mental disorders, etc.) were not included in the study. Montreal cognitive assessment (MoCA) was done for all participants by an expert examiner using MoCA tool. Results Mild cognitive impairment was confirmed in 22% of diabetic patients and in 9% of control group (p < 0.05) with total MoCA score lower in diabetic group than control one (p < 0.01). Conclusion Type 2 diabetes may be associated with lower levels of cognitive function.

Sign in / Sign up

Export Citation Format

Share Document